LAMEDITECH Statistics

Total Valuation

LAMEDITECH has a market cap or net worth of KRW 60.08 billion. The enterprise value is 61.64 billion.

Market Cap	60.08B
Enterprise Value	61.64B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

LAMEDITECH has 8.77 million shares outstanding. The number of shares has increased by 14.62% in one year.

Current Share Class	8.77M
Shares Outstanding	8.77M
Shares Change (YoY)	+14.62%
Shares Change (QoQ)	-0.09%
Owned by Insiders (%)	30.43%
Owned by Institutions (%)	0.00%
Float	4.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.14
PB Ratio	5.33
P/TBV Ratio	5.52
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.54
EV / Sales	8.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.35

Financial Position

The company has a current ratio of 7.15, with a Debt / Equity ratio of 0.44.

Current Ratio	7.15
Quick Ratio	3.47
Debt / Equity	0.44
Debt / EBITDA	n/a
Debt / FCF	-0.35
Interest Coverage	-112.65

Financial Efficiency

Return on equity (ROE) is -66.30% and return on invested capital (ROIC) is -35.25%.

Return on Equity (ROE)	-66.30%
Return on Assets (ROA)	-31.17%
Return on Invested Capital (ROIC)	-35.25%
Return on Capital Employed (ROCE)	-61.77%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.33
Inventory Turnover	1.33

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.64% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-24.64%
50-Day Moving Average	7,101.00
200-Day Moving Average	7,638.65
Relative Strength Index (RSI)	47.99
Average Volume (20 Days)	290,716

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LAMEDITECH had revenue of KRW 7.38 billion and -11.13 billion in losses. Loss per share was -1,277.58.

Revenue	7.38B
Gross Profit	3.00B
Operating Income	-11.12B
Pretax Income	-11.13B
Net Income	-11.13B
EBITDA	-10.54B
EBIT	-11.12B
Loss Per Share	-1,277.58

Full Income Statement

Balance Sheet

The company has 3.38 billion in cash and 4.94 billion in debt, giving a net cash position of -1.56 billion or -177.70 per share.

Cash & Cash Equivalents	3.38B
Total Debt	4.94B
Net Cash	-1.56B
Net Cash Per Share	-177.70
Equity (Book Value)	11.27B
Book Value Per Share	1,286.20
Working Capital	9.51B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.14 billion and capital expenditures -2.02 billion, giving a free cash flow of -14.16 billion.

Operating Cash Flow	-12.14B
Capital Expenditures	-2.02B
Free Cash Flow	-14.16B
FCF Per Share	-1,614.52

Full Cash Flow Statement

Margins

Gross margin is 40.71%, with operating and profit margins of -150.72% and -150.84%.

Gross Margin	40.71%
Operating Margin	-150.72%
Pretax Margin	-150.84%
Profit Margin	-150.84%
EBITDA Margin	-142.84%
EBIT Margin	-150.72%
FCF Margin	n/a

Dividends & Yields

LAMEDITECH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.62%
Shareholder Yield	-14.62%
Earnings Yield	-18.53%
FCF Yield	-23.57%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LAMEDITECH has an Altman Z-Score of 1.19 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.19
Piotroski F-Score	1